ITPR1 and Huntington disease: These findings led Tang et al. to propose a novel therapy for HD, who introduced IC10 peptide into HD MSNs in trans to disrupt the pathogenic association between IP3R1 and mHTT to normalize neuronal Ca2+ signaling and prevent the cell death of HD MSNs.